Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 4
2007 3
2008 5
2009 12
2010 3
2011 8
2012 7
2013 5
2014 9
2015 5
2016 8
2017 6
2018 11
2019 5
2020 15
2021 14
2022 18
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Yamamoto Y, Iwata H, Taira N, Masuda N, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Saji S, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Among authors: taira n. Cancer Sci. 2022 Sep;113(9):3169-3179. doi: 10.1111/cas.15474. Epub 2022 Jul 23. Cancer Sci. 2022. PMID: 35754298 Free PMC article. Clinical Trial.
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy.
Iwata H, Yamamoto Y, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Ohtani S, Kashiwaba M, Taira N, Toyama T, Fujisawa T, Masuda N, Shibahara Y, Sasano H, Yamaguchi T. Iwata H, et al. Among authors: taira n. Breast Cancer Res Treat. 2023 Jun;199(2):231-241. doi: 10.1007/s10549-023-06874-7. Epub 2023 Mar 22. Breast Cancer Res Treat. 2023. PMID: 36947277 Free PMC article. Clinical Trial.
Desmoid-type fibromatosis of the breast mimicking cancer.
Otani Y, Taira N, Doihara H. Otani Y, et al. Among authors: taira n. Jpn J Clin Oncol. 2020 Sep 5;50(9):1084-1085. doi: 10.1093/jjco/hyz209. Jpn J Clin Oncol. 2020. PMID: 32083288 No abstract available.
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer.
Suzuki Y, Iwamoto T, Uno M, Hatono M, Kajiwara Y, Takahashi Y, Kochi M, Shien T, Kikawa Y, Uemura Y, Hagiwara Y, Yamamoto S, Taira N, Doihara H, Toyooka S. Suzuki Y, et al. Among authors: taira n. Breast Cancer. 2023 Sep;30(5):856-868. doi: 10.1007/s12282-023-01480-3. Epub 2023 Jul 8. Breast Cancer. 2023. PMID: 37422608
Evaluation of Prognosis of Juvenile Differentiated Thyroid Carcinoma.
Tsukioki T, Shien T, Ohtani Y, Fujihara M, Suzuki Y, Kajihara Y, Hatono M, Kawada K, Kochi M, Iwamoto T, Ikeda H, Taira N, Doihara H. Tsukioki T, et al. Among authors: taira n. Acta Med Okayama. 2020 Oct;74(5):401-406. doi: 10.18926/AMO/60799. Acta Med Okayama. 2020. PMID: 33106695 Free article.
125 results